RARA and breast cancer: Although it is not possible to identify which RAR mediates the effects in the cell line model since all three RAR are present, the proliferation effects are consistent with the significant association observed between high expression of both MR and RARB with better breast cancer disease-specific survival in the METABRIC breast cancer cohort.